Music to Enhance Auditory Encoding in Young Children
Launched by CHINESE UNIVERSITY OF HONG KONG · Oct 18, 2020
Trial Information
Current as of August 19, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial, called "Music to Enhance Auditory Encoding in Young Children," is exploring whether participating in music activities can help young children learn language better. The study involves healthy infants and toddlers, who will be divided into two groups: one group will take part in music activities, while the other will engage in arts and crafts. Researchers will assess the children's ability to understand speech and their language skills before and after the activities to see if music makes a difference.
To participate in this trial, children must be full-term infants and come from families where Cantonese is the main language spoken. Unfortunately, infants who do not pass a hearing test or have certain developmental conditions will not be eligible to join. If your child is selected, they can expect to enjoy engaging activities while helping researchers learn more about the benefits of music on language development. This study is currently looking for participants, and your involvement could contribute to important findings in early childhood language skills!
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Full-term infants, and their caregivers
- • From families where Cantonese is the dominant language
- Exclusion Criteria:
- • Infants reported to fail the hearing sensitivity screening
- • Infants with mental or neuro-motor disabilities associated with atypical development (e.g. birth asphyxia; major injuries; hypoxic-ischemic injury; significant growth restriction, and other indications of neurological abnormalities
About Chinese University Of Hong Kong
The Chinese University of Hong Kong (CUHK) is a prestigious research institution renowned for its commitment to advancing medical science and improving healthcare outcomes. As a clinical trial sponsor, CUHK leverages its extensive academic resources and interdisciplinary expertise to conduct innovative research that addresses critical health challenges. The university fosters collaboration among leading researchers, healthcare professionals, and industry partners, ensuring rigorous study design and implementation. CUHK is dedicated to upholding the highest ethical standards in clinical research, with a focus on translating findings into tangible benefits for patients and the broader community.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Hong Kong, , Hong Kong
Patients applied
Trial Officials
Patrick Chun Man Wong
Principal Investigator
Chinese University of Hong Kong
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials